会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Plastic lens for spectacles
    • 塑料镜片眼镜
    • US20060158747A1
    • 2006-07-20
    • US11039261
    • 2005-01-18
    • Yuji KatoNaoyuki IshiiKaname Hase
    • Yuji KatoNaoyuki IshiiKaname Hase
    • G02B3/08
    • G02B1/041B29D11/00865G02B27/022
    • A plastic lens of a multilayer film structure forms an organosiloxane-based hard coating film formed on a surface of a lens substrate as a first layer, an inorganic oxide-based antireflection film formed on the hard coating film as a second layer, and a water-repellent thin film obtained by polycondensing an organosilicon compound and formed on the antireflection film as a third layer, pencil hardness of the surface of the lens on which these plural layer films are formed being from 3H to 7H, and an initial falling angle of oleic acid on the surface of the lens on which these plural layer films are formed being 20° or less.
    • 多层膜结构的塑料透镜形成在作为第一层的透镜基板的表面上形成的有机硅氧烷类硬涂膜,形成在作为第二层的硬涂膜上的无机氧化物系防反射膜,以及水 通过将形成在防反射膜上的有机硅化合物缩聚而形成的有机硅化合物作为第三层获得的薄膜,其上形成有多层膜的透镜的表面的铅笔硬度为3H至7H,以及油酸的初始下降角 形成这些多层膜的透镜的表面上的酸为20°以下。
    • 2. 发明授权
    • Plastic lens for spectacles
    • 塑料镜片眼镜
    • US07178919B2
    • 2007-02-20
    • US11039261
    • 2005-01-18
    • Yuji KatoNaoyuki IshiiKaname Hase
    • Yuji KatoNaoyuki IshiiKaname Hase
    • G02C7/02
    • G02B1/041B29D11/00865G02B27/022
    • A plastic lens of a multilayer film structure forms an organosiloxane-based hard coating film formed on a surface of a lens substrate as a first layer, an inorganic oxide-based antireflection film formed on the hard coating film as a second layer, and a water-repellent thin film obtained by polycondensing an organosilicon compound and formed on the antireflection film as a third layer, pencil hardness of the surface of the lens on which these plural layer films are formed being from 3H to 7H, and an initial falling angle of oleic acid on the surface of the lens on which these plural layer films are formed being 20° or less.
    • 多层膜结构的塑料透镜形成在作为第一层的透镜基板的表面上形成的有机硅氧烷类硬涂膜,形成在作为第二层的硬涂膜上的无机氧化物系防反射膜,以及水 通过将形成在防反射膜上的有机硅化合物缩聚而形成的有机硅化合物作为第三层获得的薄膜,其上形成有多层膜的透镜的表面的铅笔硬度为3H至7H,以及油酸的初始下降角 形成这些多层膜的透镜的表面上的酸为20°以下。
    • 3. 发明授权
    • Processes for the preparation of tricyclic amino alcohol derivatives
    • 制备三环氨基醇衍生物的方法
    • US06696573B1
    • 2004-02-24
    • US10070249
    • 2002-03-04
    • Koki MatsubaraNaoyuki IshiiMasami Ogawa
    • Koki MatsubaraNaoyuki IshiiMasami Ogawa
    • C07D20988
    • C07D307/91C07C205/26C07C205/45C07D209/88C07D333/76
    • A process for the preparation of tricyclic amino alcohol derivatives including 2-[N-[2-(9H-carbazol-2-yloxy)ethyl]]amino-1-[(3-methylsulfonylamino)phenyl]ethanol useful in the treatment of diabetes, obesity, hyperlipidemia and so on; and intermediates as represented by formula (5) or (6) or the like useful in the preparation, wherein R11 is hydrogen or the like; and *1 represents an asymmetric carbon atom. 2-Halo-1-(3-nitrophenyl)ethanone derivatives and 1-(3-nitrophenyl)oxirane derivatives, which are intermediates for the preparation of tricyclic amino alcohol derivatives, are easy of purification, and particularly optically active 1-(3-nitrophenyl)oxirane derivatives are effective in enhancing the optical purities of the final products.
    • 一种制备三环氨基醇衍生物的方法,包括用于治疗糖尿病的2- [N- [2-(9H-咔唑-2-基氧基)乙基]]氨基-1 - [(3-甲基磺酰基氨基)苯基]乙醇 ,肥胖,高脂血症等; 和由式(5)或(6)表示的中间体,其中R 11为氢等; * 1表示不对称碳原子。 2-卤代-1-(3-硝基苯基)乙酮衍生物和作为制备三环氨基醇衍生物的中间体的1-(3-硝基苯基)环氧乙烷衍生物易于纯化,特别是光学活性的1-(3- 硝基苯基)环氧乙烷衍生物有效提高最终产品的光学纯度。
    • 6. 发明申请
    • Electrophotographic recording material
    • 电子照相记录材料
    • US20060199000A1
    • 2006-09-07
    • US11366559
    • 2006-03-03
    • Naoyuki Ishii
    • Naoyuki Ishii
    • B32B27/18
    • G03G7/008G03G7/0013G03G7/002G03G7/0026G03G7/0066Y10T428/256Y10T428/31504
    • The present invention provides an electrophotographic recording material which attains improved levels of toner fixability, prevention of toner dispersion, prevention of unevenness in toner images, and excellent image density, as well as excellent toner image quality, high image transferrability, and high image density, and which exhibits improved sheet feeding performance in a printer. The electrophotographic recording material formed of a plastic support film, and a toner fixation layer provided on at least one surface of the plastic support film and containing a tin oxide, wherein the tin oxide is stannic oxide; the toner fixation layer has a surface resistivity A (Ω) of 1×109 to 1×1014 Ω as measured at 23° C. and a relative humidity of 50%; and the recording material has a volume resistivity B (Ω·cm) as measured at 23° C. and a relative humidity of 50% which is controlled so that a ratio (B/A) falls within a range of 1×102 to 1×105.
    • 本发明提供了一种电子照相记录材料,其具有改进的调色剂定影性,防止调色剂分散,防止调色剂图像不均匀,以及优异的图像浓度,以及优异的调色剂图像质量,高图像转印性和高图像密度, 并且其在打印机中表现出改善的片材进给性能。 由塑料支撑膜形成的电子照相记录材料和设置在塑料支撑膜的至少一个表面上并含有氧化锡的调色剂固定层,其中氧化锡是氧化锡; 调色剂固着层在23℃和相对湿度为50%时测得的表面电阻率A(Ω)为1×10 9至1×10 14Ω; 并且记录材料在23℃和相对湿度为50%下测量的体积电阻率B(Ω·cm),其被控制使得比率(B / A)落在1×10-2的范围内 至1×10 5。
    • 7. 发明授权
    • Crystals of substituted phenylalkanoic acid and method of producing the same
    • 取代苯基链烷酸的晶体及其制备方法
    • US07754752B2
    • 2010-07-13
    • US12483814
    • 2009-06-12
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • A61K31/416C07D231/56
    • C07D231/56
    • In the case of using 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, or methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate as a medicine, more preferable aspects or improved methods are provided.Crystals of any compound among 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, and methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate, and methods of producing the same are provided.
    • 在使用3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸的情况下,使用3- [4-(茚满) -2-氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸乙酯或3- [3-氨基-4-(茚满-2-基氧基)-5-( 1-甲基-1H-吲唑-5-基)苯基]丙酸乙酯,更优选的方案或改进的方法。 3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸,3- [4-(茚满酮)的任何化合物的晶体 -2-基氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸甲酯和3- [3-氨基-4-(茚满-2-基氧基)-5-( 1-甲基-1H-吲唑-5-基)苯基]丙酸乙酯及其制备方法。
    • 8. 发明授权
    • Crystal forms of substituted phenylalkanoic acids and process for producing the same
    • 取代苯基链烷酸的晶体形式及其制备方法
    • US07560478B2
    • 2009-07-14
    • US11826999
    • 2007-07-19
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • A61K31/416C07D231/56
    • C07D231/56
    • In the case of using 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, or methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate as a medicine, more preferable aspects or improved methods are provided.Crystals of any compound among 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, and methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate, and methods of producing the same are provided.
    • 在使用3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸的情况下,使用3- [4-(茚满) -2-氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸乙酯或3- [3-氨基-4-(茚满-2-基氧基)-5-( 1-甲基-1H-吲唑-5-基)苯基]丙酸乙酯,更优选的方案或改进的方法。 3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸,3- [4-(茚满酮)的任何化合物的晶体 -2-基氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸甲酯和3- [3-氨基-4-(茚满-2-基氧基)-5-( 1-甲基-1H-吲唑-5-基)苯基]丙酸乙酯及其制备方法。
    • 10. 发明申请
    • Novel crystal forms of substituted phenylalkanoic acids and process for producing the same
    • 取代苯基链烷酸的新型晶体形式及其制备方法
    • US20080070967A1
    • 2008-03-20
    • US11826999
    • 2007-07-19
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • A61K31/415C07D231/56
    • C07D231/56
    • [Object] In the case of using 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, or methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate as a medicine, more preferable aspects or improved methods are provided. [Means] Crystals of any compound among 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, and methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate, and methods of producing the same are provided.
    • 在使用3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸的情况下,将3- [4 - (茚满-2-基氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸乙酯或3- [3-氨基-4-(茚满-2-基氧基) - 5-(1-甲基-1H-吲唑-5-基)苯基]丙酸乙酯作为药物,提供更优选的方面或改进的方法。 [表示] 3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸的3- [4 - (茚满-2-基氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸乙酯和3- [3-氨基-4-(茚满-2-基氧基) - 5-(1-甲基-1H-吲唑-5-基)苯基]丙酸酯及其制备方法。